Christina Rautenberg

Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Thomas Schroeder, Christina Rautenberg, William Krüger et al. · Annals of Hematology · 2017 · 75 citations

Cell Therapy, Transplantation, Marrow Transplantation +7

Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia

Thomas Schroeder, Nadija Wegener, Michael Lauseker et al. · Biology of Blood and Marrow Transplantation · 2019 · 75 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Ctx Group +19

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib et al. · Annals of Hematology · 2020 · 65 citations · Full text

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

Christina Rautenberg, Friedrich Stölzel, Christoph Röllig et al. · Blood Cancer Journal · 2021 · 62 citations · Full text

Sorafenib and azacitidine as salvage therapy for relapse of <scp>FLT</scp>3‐<scp>ITD</scp> mutated <scp>AML</scp> after allo‐<scp>SCT</scp>

Christina Rautenberg, Kathrin Nachtkamp, Ariane Dienst et al. · European Journal Of Haematology · 2016 · 47 citations